The present technology provides triazolones, tetrazolones, and imidazolones, or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolones, tetrazolones, and imidazolones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
该技术提供了
三唑酮,
四唑酮和
咪唑酮,或其药学上可接受的盐,其制备方法,包含它们的制药组合物以及它们的用途。
三唑酮,
四唑酮和
咪唑酮或其药学上可接受的盐表现出对VAP-1的抑制活性,因此可以用于治疗和预防非
酒精性脂肪性肝病(NASH)等疾病。